According to the Breast Cancer Information Core (BIC) database [2], the majority of germline alterations identified in BRCA1 and BRCA2 is unique (57% and 63%, respectively); the remaining ones are recurrent founder mutations which have been described in different ethnic groups and populations [3]. Here, BRCA2 is linked to breast carcinoma.